Sales-tax break for appliances starts Friday
If you're in the market for new energy-efficient appliances, this weekend could be the time to buy.
The state's tax-free-holiday weekend for Energy Star and WaterSense products runs from Friday until Sunday. Floridians won't pay sales tax on the first $1,500 they spend. The tax break starts at 12:01 a.m. Friday and ends at 11:59 p.m. Sunday.
Energy Star qualified items include air purifiers, ceiling fans, clothes dryers and washers, dehumidifiers, dishwashers, freezers, packages of light bulbs, refrigerators, air conditioners, swimming-pool pumps and water heaters.
WaterSense appliances include bathroom-sink faucets, certain faucet accessories, high-efficiency toilets or urinals, shower heads and weather- or sensor-based irrigation controllers.
State officials say the weekend should result in about $1.7 million in savings for consumers.
Pizza Hut testing lighter pizza called `skinny slice'
NEW YORK -- Pizza Hut is testing out a lighter pizza in two U.S. markets as it seeks to freshen up its menu and regain its footing against competitors.
The tests of the "Skinny Slice" pies began this week at several dozen restaurants in Toledo, Ohio, and West Palm Beach in south Florida. The pies simply use less of the same dough used for regular pies and are lighter on the toppings, said Doug Terfehr, a Pizza Hut spokesman.
Several fast-food and restaurant chains have turned to lighter offerings over the years as a way to update their images, with varying degrees of success.
Burger King, for instance, recently said the majority of its U.S. restaurants would stop offering lower-calorie french fries less than a year after the so-called "Satisfries" were introduced.
FDA approves Eli Lilly's injectable diabetes drug
WASHINGTON -- The Food and Drug Administration has approved a new injectable diabetes drug from Eli Lilly and Co. for adults with the most common form of the disease.
The agency on Thursday cleared the drug, Trulicity, as a weekly injection to improve blood sugar control in patients with type 2 diabetes, which affects more than 26 million Americans. The drug is part of a new class of medicines called GLP-1 agonists, which spur the pancreas to create extra insulin after meals.
Type 2 diabetes accounts for 90 percent of U.S. cases of the disease and occurs when the body doesn't properly produce or use the hormone insulin. Drugs to treat the disease represent a large slice of Lilly's product portfolio, which includes the insulins Humalog and Humulin.
Herald wire reports